全文获取类型
收费全文 | 10117807篇 |
免费 | 648228篇 |
国内免费 | 162198篇 |
专业分类
耳鼻咽喉 | 131249篇 |
儿科学 | 283063篇 |
妇产科学 | 231887篇 |
基础医学 | 1254432篇 |
口腔科学 | 264799篇 |
临床医学 | 1024543篇 |
内科学 | 1689312篇 |
皮肤病学 | 204080篇 |
神经病学 | 729913篇 |
特种医学 | 377709篇 |
外国民族医学 | 1666篇 |
外科学 | 1331407篇 |
综合类 | 724120篇 |
现状与发展 | 515篇 |
一般理论 | 3738篇 |
预防医学 | 809179篇 |
眼科学 | 229883篇 |
药学 | 873147篇 |
3066篇 | |
中国医学 | 217857篇 |
肿瘤学 | 542668篇 |
出版年
2022年 | 105690篇 |
2021年 | 199992篇 |
2020年 | 142823篇 |
2019年 | 146085篇 |
2018年 | 178327篇 |
2017年 | 159175篇 |
2016年 | 154828篇 |
2015年 | 198689篇 |
2014年 | 283034篇 |
2013年 | 373479篇 |
2012年 | 525912篇 |
2011年 | 570900篇 |
2010年 | 387912篇 |
2009年 | 348593篇 |
2008年 | 486225篇 |
2007年 | 506417篇 |
2006年 | 483144篇 |
2005年 | 444759篇 |
2004年 | 390430篇 |
2003年 | 361883篇 |
2002年 | 333115篇 |
2001年 | 313458篇 |
2000年 | 311566篇 |
1999年 | 266491篇 |
1998年 | 111195篇 |
1997年 | 97766篇 |
1996年 | 91828篇 |
1995年 | 83903篇 |
1994年 | 76067篇 |
1993年 | 65067篇 |
1992年 | 183037篇 |
1991年 | 177028篇 |
1990年 | 171686篇 |
1989年 | 166610篇 |
1988年 | 154072篇 |
1987年 | 150010篇 |
1986年 | 142880篇 |
1985年 | 136162篇 |
1984年 | 103701篇 |
1983年 | 89031篇 |
1982年 | 56713篇 |
1979年 | 93068篇 |
1978年 | 66797篇 |
1977年 | 57599篇 |
1976年 | 53397篇 |
1975年 | 58435篇 |
1974年 | 67413篇 |
1973年 | 64320篇 |
1972年 | 59451篇 |
1971年 | 55071篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
141.
Melanie A. Krook Julie W. Reeser Gabrielle Ernst Hannah Barker Max Wilberding Gary Li Hui-Zi Chen Sameek Roychowdhury 《British journal of cancer》2021,124(5):880
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this review by highlighting the diversity of FGFR genomic alterations identified in human cancers and the current challenges associated with the development of clinical-grade molecular diagnostic tests to accurately detect these alterations in the tissue and blood of patients. The past decade has seen significant advancements in the development of FGFR-targeted therapies, which include selective, non-selective and covalent small-molecule inhibitors, as well as monoclonal antibodies against the receptors. We describe the expanding landscape of anti-FGFR therapies that are being assessed in early phase and randomised controlled clinical trials, such as erdafitinib and pemigatinib, which are approved by the Food and Drug Administration for the treatment of FGFR3-mutated urothelial carcinoma and FGFR2-fusion cholangiocarcinoma, respectively. However, despite initial sensitivity to FGFR inhibition, acquired drug resistance leading to cancer progression develops in most patients. This phenomenon underscores the need to clearly delineate tumour-intrinsic and tumour-extrinsic mechanisms of resistance to facilitate the development of second-generation FGFR inhibitors and novel treatment strategies beyond progression on targeted therapy.Subject terms: Cancer, Cancer 相似文献
142.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
143.
目的 基于“伏风暗瘀宿痰”小儿哮喘病机新说,采用网络药理学及实验验证的方法,探索搜风愈喘方拆方“祛宿痰方”治疗儿童哮喘的作用机制,验证中医“宿痰”病机与西医细胞外基质改变病理之间的交通性。方法 通过TCMSP数据库建立“祛宿痰方”的有效成分和靶点数据集,利用OMIM、GeneCards、DrugBank、TTD疾病数据库建立哮喘疾病靶点数据集,利用Cytoscape软件取交集并构建“祛宿痰方”与哮喘的蛋白质互作网络,筛选关键靶点蛋白。利用Metascape数据库进行基因本体(Gene ontology,GO)分析以及京都基因和基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)富集分析。复制卵蛋白(OVA)诱导的哮喘大鼠模型,对核心通路及关键靶点进行实验验证。结果 共得到“祛宿痰方”治疗哮喘的靶点98个,包括IL-13、TP53、TGF-β1、VEGF-A、MMP9等,KEGG得到与哮喘相关的通路287条(P<0.05),包括NF-κB信号通路、PI3K-AKT信号通路、IL-17信号通路等。GO结果显示与哮喘相关生物进程包括炎症反应、细胞外基质调控、氧化应激、血管生成等。动物实验证实“祛宿痰方”可下调大鼠肺组织中p-NF-κB-P65磷酸化水平,抑制NF-κB信号通路的激活,降低IL-13、TGF-β1 mRNA表达量(P<0.05),减少哮喘大鼠肺组织中炎症细胞浸润、黏液产生,从而延缓哮喘的进程。结论 “祛宿痰方”可抑制NF-κB信号通路的激活,降低肺组织中IL-13、TGF-β1 mRNA表达量,可能通过抑制炎症反应、调控细胞外基质等途径作用于哮喘,中医“宿痰”病机与西医细胞外基质改变病理之间存在一定的的交通性。 相似文献
144.
145.
Background:We aim to evaluate the efficiency of Raman spectroscopy (RS) in diagnosing suspected patients with intrahepatic cholangiocarcinoma (ICC), manifested by diagnostic sensitivity, specificity, and accuracy.Methods:We will research widely the articles concerning the use of RS in ICC through authenticated database including PubMed/Medline, EMBASE, Web of Science, Ovid, Web of Knowledge, Cochrane Library, and CNKI between January 2012 and November 2020, retrieving at least 1500 spectra with strict criteria. This study will be carried out in accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We are going to summarize the test performance using random effects models.Results:Based on the pooled sensitivity, specificity, and diagnostic accuracy, we intend to provide the relative diagnostic efficiency in ICC through RS.Conclusion:Through this systematic review and meta-analysis, we intend to provide the pooled sensitivity, specificity and diagnostic accuracy of RS in the diagnosis of suspected ICC. Other parameters like positive likelihood ratios (LR), negative LR, diagnostic odds ratio (DOR), and area under curve (AUC) of the summary receiver operating characteristics (SROC) curve will also be calculated and related figures will be drawn to help illustrate the efficacy of RS in the diagnosis of ICC. 相似文献
146.
147.
148.
Anela Stanic Denis Rybin Francis Cannata Carole Hohl Jennifer Brody Jessie Gaeta 《AIDS care》2021,33(1):1-9
ABSTRACT The lack of stable housing can impair access and continuity of care for patients living with human immunodeficiency virus (HIV). This study investigated the relationship between housing status assessed at multiple time points and several core HIV-related outcomes within the same group of HIV patients experiencing homelessness. Patients with consistently stable housing (CSH) during the year were compared to patients who lacked CSH (non-CSH group). The study outcomes included HIV viral load (VL), CD4 counts, and health care utilization. Multivariable and propensity weighted analyses were used to assess outcomes adjusting for potential group differences. Of 208 patients, 88 (42%) had CSH and 120 (58%) were non-CSH. Patients with CSH had significantly higher proportion of VL suppression and higher mean CD4 counts. The frequency of nurse visits in the CSH group was less than a half of that in the non-CSH group. Patients with CSH were less likely to be admitted to the medical respite facility, and if admitted, their length of stay was about a half of that for the non-CSH group. Our study findings show that patients with CSH had significantly better HIV virologic control and immune status as well as improved health care utilization. 相似文献
149.
150.